Research + Education
The University of Michigan Rogel Cancer Center has a distinguished history of scientific excellence, collaboration and impact in basic science, clinical research and cancer control research.
News
-
Haymart gets $3.3M to develop risk-based approach to thyroid cancer survivorship care
Do all thyroid cancer survivors need the same level of follow-up care and monitoring? With a new $3.3 million grant from the National Cancer Institute, Megan Haymart, M.D., will identify survivors at different risks of recurrence and develop a system for long-term monitoring based on that risk.Read More > -
With $5M grant, Rogel team will conduct preclinical work to develop drugs targeting cancer master regulator
University of Michigan Rogel Cancer Center researcher Arul Chinnaiyan, M.D., Ph.D., has received a $5 million grant from the J.C. Kennedy Foundation to conduct laboratory tests of a potential drug candidate targeting a master regulator that controls the majority of genes involved in the most challenging type of prostate cancer.Read More > -
Zhou gets $2.9M to develop a system to predict outcomes in multiple myeloma
By combining data from MRI scans and clinical tests, University of Michigan Rogel Cancer Center researcher Chuan Zhou, Ph.D., will develop a decision support tool to tailor treatment for individual patients with multiple myeloma. It’s a cancer that’s considered incurable, with survival ranging from less than a year to more than a decade, depending on the extent and aggressiveness of the tumors.Read More > -
AACR 2024: Rogel Recap of the 2024 AACR Annual Meeting
Highlights from Rogel's presence at the 2024 AACR Annual MeetingRead More >
Multimedia + Social Media